Katarzyna M. Targowska‐Duda

Volatile terpenoids as potential drug leads in Alzheimer’s disease

Karolina Wojtunik‐Kulesza, Katarzyna M. Targowska‐Duda, Katarzyna Klimek et al. · Open Chemistry · 2017 · 50 citations · Full text

Molecular Pharmacology, Neurodegenerative Diseases, Alzheimer's Disease +13

6-Gingerol, a Major Constituent of Zingiber officinale Rhizoma, Exerts Anticonvulsant Activity in the Pentylenetetrazole-Induced Seizure Model in Larval Zebrafish

Wirginia Kukuła‐Koch, Nancy Saana Banono, Dorota Nieoczym et al. · International Journal of Molecular Sciences · 2021 · 45 citations · Full text

Interaction of Bupropion with Muscle-Type Nicotinic Acetylcholine Receptors in Different Conformational States

Hugo R. Arias, Fernanda Gumilar, Avraham Rosenberg et al. · Biochemistry · 2009 · 44 citations · Full text

Neuropeptides, Synaptic Transmission, Neurotransmitter +20

In vitro, molecular modeling and behavioral studies of 3-{[4-(5-methoxy-1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]methyl}-1,2-dihydroquinolin-2-one (D2AAK1) as a potential antipsychotic

Agnieszka A. Kaczor, Katarzyna M. Targowska‐Duda, Barbara Budzyńska et al. · Neurochemistry International · 2016 · 38 citations

Behavioral Studies, Medicinal Chemistry, Neuropsychology +13

Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications

Izabela Zakrocka, Katarzyna M. Targowska‐Duda, Artur Wnorowski et al. · Neurotoxicity Research · 2017 · 36 citations · Full text